|
Index of reports
> Cases resulting in disability (66)
> Cases with Myalgia (13)
Below is the selection of adverse event reports related to Crestor (Rosuvastatin) that includes cases resulting in disability where reactions include myalgia.
Adverse event in 78 year old female receiving Crestor (Rosuvastatin)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 78 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Myalgia, Hemiplegia
Adverse event resulted in: disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Synthroid
Adverse event in 69 year old male receiving Crestor (Rosuvastatin)
Reported by a physician from Belgium on 2007-10-24
Patient: 69 year old male
Adverse reactions / side effects: Myalgia, Fatigue, Muscle Swelling, Arthralgia, Bradycardia, Muscle Spasms
Adverse event resulted in: disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Amlor; Persantine
Adverse event in 605 month old male receiving Crestor (Rosuvastatin)
Reported by a physician from United Kingdom on 2007-10-18
Patient: 605 month old male
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Nasopharyngitis, Diabetes Mellitus, Haemorrhage, Dyskinesia, Wheezing, Eczema, Pyrexia, Feeling Cold, Speech Disorder, Conjunctivitis Allergic, Myalgia, Balance Disorder, Carpal Tunnel Syndrome, Rhinorrhoea, Psoriasis, Ill-Defined Disorder, Hepatocellular Damage, Tremor, Dysgeusia, Arthralgia, Sleep Disorder, Ocular Hyperaemia, Psoriatic Arthropathy
Adverse event resulted in: disablity
Suspect drug(s):
Crestor
Administration route: Oral
Start date: 2004-01-05
End date: 2004-05-14
Atorvastatin Calcium
Administration route: Oral
Start date: 2002-11-18
End date: 2004-01-01
Cerivastatin
Administration route: Oral
Start date: 2000-05-03
End date: 2001-08-28
Fenofibrate
Administration route: Oral
Start date: 2000-03-22
End date: 2000-08-01
Other drugs received by patient: Calcipotriene; Gliclazide; Gliclazide; Sulfasalazine
Adverse event in 80 year old female receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-07-27
Patient: 80 year old female, weighing 55.8 kg (122.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Rhabdomyolysis, Dyslexia, Speech Disorder, Myalgia, Fatigue, Tongue Disorder, DRY Mouth, Bone Disorder, Myositis, Chondropathy, Dyspnoea, Dysphagia, Atrial Fibrillation, Myopathy, Hepatic Enzyme Increased, Tremor, Dysphemia, Diarrhoea, Dysphonia, Dysuria, Vaginal Infection, Asthenia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-03-21
End date: 2006-08-18
Crestor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-03-21
End date: 2006-08-18
Crestor
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2006-03-21
End date: 2006-08-18
Other drugs received by patient: Flecainide Acetate; Antivert; Xanax; Warfarin Sodium; Cholestyramine; Carafate; M.v.i.; Namenda; Citracal + D; Verapamil; Halcion
Adverse event in 80 year old female receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-07-26
Patient: 80 year old female, weighing 55.8 kg (122.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Rhabdomyolysis, Dyslexia, Speech Disorder, Myalgia, Fatigue, Tongue Disorder, DRY Mouth, Bone Disorder, Myositis, Chondropathy, Dyspnoea, Dysphagia, Atrial Fibrillation, Myopathy, Hepatic Enzyme Increased, Tremor, Dysphemia, Diarrhoea, Dysphonia, Dysuria, Vaginal Infection, Asthenia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-03-21
End date: 2006-08-18
Crestor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-03-21
End date: 2006-08-18
Crestor
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2006-03-21
End date: 2006-08-18
Other drugs received by patient: Flecainide Acetate; Antivert; Xanax; Warfarin Sodium; Cholestyramine; Carafate; M.v.i.; Namenda; Citracal + D; Verapamil; Halcion
Adverse event in female receiving Crestor (Rosuvastatin)
Reported by a physician from Ireland on 2007-07-23
Patient: female
Adverse reactions / side effects: Myalgia, Pernicious Anaemia
Adverse event resulted in: disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Adverse event in 80 year old female receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-06-25
Patient: 80 year old female, weighing 55.8 kg (122.8 pounds)
Adverse reactions / side effects: Myalgia, Abdominal Pain, Myositis, Fatigue, Rhabdomyolysis, Diarrhoea, Asthenia, Hepatic Enzyme Increased, Tremor
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-03-21
End date: 2006-08-18
Crestor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-03-21
End date: 2006-08-18
Other drugs received by patient: Flecainide Acetate; Antivert; Xanax; Warfarin Sodium; Cholestyramine; Carafate; M.v.i.; Namenda; Citracal + D; Verapamil; Halcion
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a consumer/non-health professional from United States on 2007-06-11
Patient: male
Adverse reactions / side effects: Myalgia, Drug Ineffective, Abasia, Intervertebral Disc Degeneration, Muscular Weakness, Muscle Spasms
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Crestor
Adverse event in 33 year old male receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-05-31
Patient: 33 year old male, weighing 102.1 kg (224.5 pounds)
Adverse reactions / side effects: Myalgia, Muscle Swelling, Contusion, Oedema Peripheral, Muscular Weakness, Testicular Swelling, Excessive Exercise, Muscle Enzyme Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a consumer/non-health professional from United States on 2007-04-28
Patient: male
Adverse reactions / side effects: Myalgia, Drug Ineffective, Abasia, Intervertebral Disc Degeneration
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Crestor
Adverse event in 57 year old male receiving Crestor (Rosuvastatin)
Reported by a physician from France on 2007-04-28
Patient: 57 year old male
Adverse reactions / side effects: Myalgia, Amyotrophy, Muscular Weakness
Adverse event resulted in: disablity
Suspect drug(s):
Tahor
Indication: Hypercholesterolaemia
Crestor
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a pharmacist from Canada on 2007-02-02
Patient: male
Adverse reactions / side effects: Myalgia, Drug Ineffective, Blood Glucose Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lantus
Start date: 2007-01-24
Crestor
Administration route: Oral
Other drugs received by patient: Altace
Adverse event in 658 month old female receiving Crestor (Rosuvastatin)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-10
Patient: 658 month old female
Adverse reactions / side effects: Cytomegalovirus Antibody Positive, Weight Decreased, Blood Creatine Phosphokinase Increased, Eye Irritation, Fall, Transaminases Increased, Muscle Enzyme Increased, Myalgia, Skin Discolouration, Skeletal Injury, Peripheral Vascular Disorder, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Varicose Vein, Mucosal Erosion, Ocular Hyperaemia, Aspartate Aminotransferase Increased, Herpes Virus Infection
Adverse event resulted in: disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-01-31
Zelitrex
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2005-12-01
End date: 2006-01-31
Other drugs received by patient: Seresta; Mepronizine; Motilium; Lamaline
|
